APA

Dale R. C., Tantsis E. M., Merheb V., Kumaran R. A., Sinmaz N., Pathmanandavel K., Ramanathan S., Booth D. R., Wienholt L. A., Prelog K., Clark D. R., Guillemin G. J., Lim C. K., Mathey E. K. & Brilot F. (20141023). Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. : Neurology(R) neuroimmunology & neuroinflammation.

Chicago

Dale Russell C, Tantsis Esther M, Merheb Vera, Kumaran Raani-Yogeeta A, Sinmaz Nese, Pathmanandavel Karrnan, Ramanathan Sudarshini, Booth David R, Wienholt Louise A, Prelog Kristina, Clark Damien R, Guillemin Gilles J, Lim Chai K, Mathey Emily K and Brilot Fabienne. 20141023. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. : Neurology(R) neuroimmunology & neuroinflammation.

Harvard

Dale R. C., Tantsis E. M., Merheb V., Kumaran R. A., Sinmaz N., Pathmanandavel K., Ramanathan S., Booth D. R., Wienholt L. A., Prelog K., Clark D. R., Guillemin G. J., Lim C. K., Mathey E. K. and Brilot F. (20141023). Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. : Neurology(R) neuroimmunology & neuroinflammation.

MLA

Dale Russell C, Tantsis Esther M, Merheb Vera, Kumaran Raani-Yogeeta A, Sinmaz Nese, Pathmanandavel Karrnan, Ramanathan Sudarshini, Booth David R, Wienholt Louise A, Prelog Kristina, Clark Damien R, Guillemin Gilles J, Lim Chai K, Mathey Emily K and Brilot Fabienne. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. : Neurology(R) neuroimmunology & neuroinflammation. 20141023.